The U.S. company Johnson & Johnson (J&J), have targeted one billion doses of its Covid-19 vaccine till next year if it proves to be successful. The company has reported that, in case they fail to find enough trials for the vaccine, they will carry out trials on healthy humans. The company will volunteer healthy humans by injecting coronavirus in the bodies of humans. J&J started its trial in July, after which they released the details of the study of vaccines on the monkeys. The large trials of the vaccine is all set to start by October and the results, if it is effective or not, will be out by the end of 2020 or mid of 2021.
Read More at Business Standard